Allergic and hypersensitivity condition in the International Patients’ Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11
IF 4.3 3区 材料科学Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Luciana Kase Tanno MD PhD, Alain Perie PhD, Jonathan A. Bernstein MD, James L. Sublett MD, Karapet Davtyan MD MPH MBA, Frederic Berard MD PhD, Ruby Pawankar MD PhD, Marylin Valentin Rostan MD, Herberto Chong MD PhD, Anahi Yañez MD, Ignacio J. Ansontegui MD PhD, Motohiro Ebisawa MD PhD, Gary W.K. Wong MD PhD, Mario Morais-Almeida MD, Bryan Martin MD, Yann Briand PhD, Pascal Demoly MD PhD, the American Academy of Allergy Asthma & Immunology (AAAAI), the American College of Allergy Asthma and Immunology (ACAAI), the Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI), the French Allergy Society (SFA), the French WHO Collaborating Centre, the WHO Regional Office for Europe, the Latin American Society of Allergy and Immunology (SLAAI), the Montpellier WHO Collaborating Centre, the World Allergy Organization (WAO)
{"title":"Allergic and hypersensitivity condition in the International Patients’ Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11","authors":"Luciana Kase Tanno MD PhD, Alain Perie PhD, Jonathan A. Bernstein MD, James L. Sublett MD, Karapet Davtyan MD MPH MBA, Frederic Berard MD PhD, Ruby Pawankar MD PhD, Marylin Valentin Rostan MD, Herberto Chong MD PhD, Anahi Yañez MD, Ignacio J. Ansontegui MD PhD, Motohiro Ebisawa MD PhD, Gary W.K. Wong MD PhD, Mario Morais-Almeida MD, Bryan Martin MD, Yann Briand PhD, Pascal Demoly MD PhD, the American Academy of Allergy Asthma & Immunology (AAAAI), the American College of Allergy Asthma and Immunology (ACAAI), the Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI), the French Allergy Society (SFA), the French WHO Collaborating Centre, the WHO Regional Office for Europe, the Latin American Society of Allergy and Immunology (SLAAI), the Montpellier WHO Collaborating Centre, the World Allergy Organization (WAO)","doi":"10.1016/j.waojou.2024.100921","DOIUrl":null,"url":null,"abstract":"In 2010, the United States Human and Health Services (US HHS) and the European Union's (EU) Directorate General for Communications Networks, Content and Technology signed a memorandum of understanding to stimulate cooperation surrounding health-related information communications technology. The key project that emerged from this agreement is the (IPS), intended to provide succinct clinically relevant patient summaries, which are generalizable and condition-independent, that can be readily used by all clinicians for the care of patients. Although allergies are included in the main information required by the IPS library and framework, it is misrepresented which leads to underdiagnosis or misdiagnosis of patients suffering from allergic and hypersensitivity conditions (A/H). The French and Montpellier World Health Organization (WHO) Collaborating Centres have provided arguments for supporting representation of A/H in the IPS. These are based on the relevance of the new classification of A/H in the WHO International Classification of Diseases 11th version (ICD-11), and the need for alignment of eHealth tools with harmonized health information. We first present the A/H in the IPS initiative with the mission of producing an international information system that can be used globally in electronic health records to standardize clinical diagnoses and facilitate communication between clinicians caring for patients with A/H diseases. It is believed this initiative will provide a strong voice for the allergy community and an effective process for improving the quality of health data that will optimize medical care for our patients worldwide.","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.waojou.2024.100921","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0
Abstract
In 2010, the United States Human and Health Services (US HHS) and the European Union's (EU) Directorate General for Communications Networks, Content and Technology signed a memorandum of understanding to stimulate cooperation surrounding health-related information communications technology. The key project that emerged from this agreement is the (IPS), intended to provide succinct clinically relevant patient summaries, which are generalizable and condition-independent, that can be readily used by all clinicians for the care of patients. Although allergies are included in the main information required by the IPS library and framework, it is misrepresented which leads to underdiagnosis or misdiagnosis of patients suffering from allergic and hypersensitivity conditions (A/H). The French and Montpellier World Health Organization (WHO) Collaborating Centres have provided arguments for supporting representation of A/H in the IPS. These are based on the relevance of the new classification of A/H in the WHO International Classification of Diseases 11th version (ICD-11), and the need for alignment of eHealth tools with harmonized health information. We first present the A/H in the IPS initiative with the mission of producing an international information system that can be used globally in electronic health records to standardize clinical diagnoses and facilitate communication between clinicians caring for patients with A/H diseases. It is believed this initiative will provide a strong voice for the allergy community and an effective process for improving the quality of health data that will optimize medical care for our patients worldwide.